Skip to main
STAA
STAA logo

STAAR Surgical (STAA) Stock Forecast & Price Target

STAAR Surgical (STAA) Analyst Ratings

Based on 7 analyst ratings
Hold
Strong Buy 0%
Buy 0%
Hold 100%
Sell 0%
Strong Sell 0%

Bulls say

Staar Surgical Co. possesses a robust market position in the ophthalmic surgical product segment, predominantly through its innovative implantable lenses used in refractive and cataract surgeries. The company demonstrates strong sales growth driven by the increasing demand for its Implantable Collamer lenses (ICL) and intraocular lenses (IOL), which cater to an expanding global population requiring vision correction. Additionally, Staar's strategic focus on developing advanced delivery systems and maintaining a dedicated niche within the ophthalmic market supports a positive outlook, despite facing competition from larger companies with more substantial financial resources.

Bears say

Staar Surgical faces potential challenges that could adversely affect its financial performance, primarily due to competitive pricing pressures from larger manufacturers, which may compress gross margins. Additionally, ongoing changes in healthcare policies and reimbursement reductions for age-related surgical products, such as intraocular lenses (IOLs) for cataracts, could hinder revenue growth. Furthermore, the risk associated with regulatory approvals for its product pipeline raises concerns about the company's capacity to expand its implantable collamer lens (ICL) market share.

STAAR Surgical (STAA) has been analyzed by 7 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 100% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About STAAR Surgical (STAA) Forecast

Analysts have given STAAR Surgical (STAA) a Hold based on their latest research and market trends.

According to 7 analysts, STAAR Surgical (STAA) has a Hold consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.71, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.71, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

STAAR Surgical (STAA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.